Archive for 2005
Financial Snapshot For June 2005
Some Resilience…
India needs a body like FDA for quality control in drugs
The health ministry has decided to set up an autonomous drug control authority on the lines of the US Food and Drugs Administration, but with a mandate going far beyond the latter.
U.S. relatively hospitable to stem-cell research
The United States appears to be a relatively hospitable place for embryonic stem cell research, especially compared to Canada and some nations in Europe where governments not only refuse financial support for human cloning to produce stem cells, they outlaw the practice.
Drug firms don’t disclose enough
The editor-in-chief of the New England Journal of Medicine accused three of the largest drug companies of ‘making a mockery‘ of efforts to create transparency in clinical trials, adding that could lead some important medical publications to avoid publishing their studies.
Alternative Stem Cell Bill Added to Debate
With a closely divided House poised to vote today on whether to expand federal funding of human embryonic stem cell research, opponents are offering fence-sitters what they say is an embryo-friendly alternative: a bill that would foster the use of stem cells from umbilical cords discarded after birth.
Giving The Green Light To Industrial Biotech
The U.S. government is dangling a big carrot — and some wheat and corn — to encourage manufacturers to make more products from biobased materials.
